TABLE 3.
Distribution of MRSA isolates typed by PFGE in Australian cities in 2000 and 2002
| Strain | No. (%) of isolates
|
|||||||
|---|---|---|---|---|---|---|---|---|
| National totals
|
Brisbane
|
Sydney
|
Canberra
|
|||||
| 2000 (n = 280) | 2002 (n = 367) | 2000 (n = 23) | 2002 (n = 33) | 2000 (n = 129) | 2002 (n = 169) | 2000 (n = 5) | 2002 (n = 8) | |
| Nonmultiresistant | ||||||||
| EMRSA-15 | 30 (10.7) | 42 (11.4) | 1 (4.3) | 1 (3.0) | 23 (17.8) | 28 (16.6) | ||
| SWP | 33 (11.8) | 26 (7.1) | 9 (39.1) | 9 (27.3) | 20 (15.5) | 6 (3.6) | 2 (40.0) | 2 (25.0) |
| WA-MRSA-1 | 45 (16.1) | 59 (16.1) | 3 (13.0) | 6 (18.2) | 4 (3.1) | 10 (5.9) | ||
| nmMRSA A | 13 (4.6) | 36 (9.8) | 1 (4.3) | 3 (9.1) | 9 (7.0) | 26 (15.4) | 1 (20.0) | 1 (12.5) |
| nmMRSA B | 14 (4.9) | 18 (4.9) | 1 (4.3) | 2 (6.1) | 1 (0.6) | 1 (20.0) | ||
| nmMRSA C | 4 (1.4) | 10 (2.7) | 2 (1.6) | 3 (1.8) | ||||
| nmMRSA D | 2 (0.7) | |||||||
| nmMRSA E | 3 (1.1) | 1 (0.3) | ||||||
| nmMRSA F | 2 (0.7) | 2 (0.5) | ||||||
| UK EMRSA-16 | 1 (0.3) | |||||||
| Sporadic | 10 (3.6) | 4 (1.1) | 2 (8.7) | 3 (2.3) | 1 (0.6) | 1 (20.0) | ||
| Subtotal | 156 (55.7) | 199 (54.2) | 17 (73.9) | 21 (63.6) | 61 (47.3) | 75 (44.4) | 5 (100) | 3 (37.5) |
| Multiresistant | ||||||||
| AUS-2 | 90 (32.1) | 123 (33.5) | 5 (21.7) | 9 (27.3) | 61 (47.3) | 88 (52.1) | 5 (62.5) | |
| AUS-3 | 18 (6.3) | 39 (10.6) | 3 (9.1) | 1 (0.8) | 2 (1.2) | |||
| Irish-2 | 1 (0.4) | |||||||
| Irish-1 | 3 (0.8) | 2 (1.2) | ||||||
| Sporadic | 15 (5.4) | 3 (0.8) | 1 (4.3) | 6 (4.7) | 2 (1.2) | |||
| Subtotal | 124 (44.3) | 168 (45.8) | 6 (26.1) | 12 (36.4) | 68 (52.8) | 94 (55.6) | 0 | 5 (62.5) |